To identify if IL-33 contributed to raised pathology in co-infection, we treated Nb + HSV-2 mice intravaginally with the IL-33 inhibitor heligmosomoides polygyrus alarmin release inhibitor (HpARI) (Figure 5D) (Osbourn et al., 2017). The gene discussed is IL33; the disease is coinfection.